Story thread · 3 reports / 3 sources
FDA approves Lilly’s Inluriyo-Verzenio combo for breast cancer
investing.com · 3h · first report
The coverage
- FDA approves Lilly's oral SERD combo for second-line breast cancer therapy
endpts.com · 1h
- Lilly wins full FDA approval for Inluriyo combo in breast cancer
seekingalpha.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.